PharmTech News

Oct 16, 2018
By Pharmaceutical Technology Editors
The new guidance, Rare Diseases: 2 Early Drug Development and the Role of Pre-IND Meetings Guidance for Industry, discusses the planning of pre-IND meetings with FDA and sponsors.
Oct 16, 2018
By Pharmaceutical Technology Editors
According to CPhI’s annual report, the therapeutic antibody drug conjugates (ADC) market is expected to reach $4 billion by 2023.
Oct 16, 2018
By Pharmaceutical Technology Editors
The guidance describes the agency's recommendations on how to group patients with different molecular alterations and approaches for evaluating the benefits and risks of targeted therapies where some molecular alterations may occur at low frequencies.
Oct 16, 2018
By Pharmaceutical Technology Editors
The agency is developing technology- and disease-specific regulatory frameworks for innovations that may not have previously had a clear development pathway.
Oct 15, 2018
By Pharmaceutical Technology Editors
The company was awarded for excellence in innovation for Parteck MXP Excipient and modified amino acids.
Oct 15, 2018
By Pharmaceutical Technology Editors
The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.
Oct 15, 2018
By Pharmaceutical Technology Editors
The company’s planned investment in its alkoxylation facility in the United States Gulf Coast will also expand production capacity for its polyethylene glycols.
Oct 15, 2018
By Pharmaceutical Technology Editors
Clovis Oncology and Lonza celebrated the grand opening of a dedicated production train at Lonza’s Visp, Switzerland site for manufacturing Rubraca (rucaparib).
Oct 12, 2018
By Pharmaceutical Technology Editors
The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.
Oct 12, 2018
By Pharmaceutical Technology Editors
A new investigational vaccine, LASSARAB, shows promise for use against Lassa fever and rabies.
native1_300x100
lorem ipsum